Stanford University
Showing 10,151-10,200 of 13,050 Results
-
John Scroggs
Division Manager, Medicine - Med/Infectious Diseases
Current Role at StanfordSenior Administrative Division Director for the Division of Infectious Diseases & Geographic Medicine within the Department of Medicine.
-
Susan Meyhak Seav
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Assistant Professor (By courtesy), NeurosurgeryBioDr. Seav is a board-certified endocrinologist and Clinical Assistant Professor in the Division of Endocrinology at Stanford and, by courtesy, the Department of Neurosurgery. She graduated from Harvard University with an honors degree in molecular and cellular biology before completing her medical education and residency at the University of California, San Diego. She then completed her endocrinology fellowship at Stanford University.
She has a special interest in disorders that involve the pituitary and adrenal glands such as acromegaly, Cushing disease, hypopituitarism, and functional adrenal adenomas. Dr. Seav is determined to provide her patients with personalized, evidence-based medicine that will allow them to live their best lives. In addition to caring for patients, Dr. Seav is also passionate about medical education and devoted a chief medical residency year teaching medical students, interns, and residents.
In-person and telehealth appointments with Dr. Seav are available at Stanford Endocrinology Clinic at Hoover Pavilion, Pituitary Center at Stanford Neurosciences Health Center, and the Stanford Brain Tumor Center at Stanford Cancer Center. -
Vittorio Sebastiano
Associate Professor (Research) of Obstetrics and Gynecology (Reproductive, Perinatal & Stem Cell Biology Research)
Current Research and Scholarly InterestsThe thread of Ariadne that connects germ cells, preimplatation development and pluripotent stem cells is the focus of my research, with a specific interest in human development. My long-term goals are: 1. Understanding the biology of germ cells and and their ability to sustain early preimplantation development; 2. Understanding the mechanisms that regulate very early cell fate decisions in human embryos; 3. Understanding the biology of derivation and maintenance of Pluripotent Stem Cells
-
Bobak Seddighzadeh
Affiliate, Department Funds
Fellow in Peds/Clinical InformaticsBioOver the past 13 years, Dr. Seddighzadeh has advanced biomedical innovation at Harvard, Stanford, and the Mayo Clinic, integrating emerging technologies with clinical medicine to improve patient care.
Dr. Seddighzadeh’s expertise spans genomic medicine, clinical informatics, and clinical AI. He has built enterprise-level clinical decision support systems that improve care at scale, and as part of the Stanford GUIDE-AI group and the Nigam Shah Lab, he focuses on developing AI-enabled clinical platforms for Stanford’s hospitals and clinics. His work in clinical AI includes implementation, evaluation, and safety guardrails. He also contributes to precision medicine efforts that use multi-omic data to identify disease subtypes and enable more individualized care. As part of Chan Zuckerberg Biohub, he helped build one of the world’s first complete human cell atlases.
In clinical practice, Dr. Seddighzadeh is committed to delivering outstanding internal medicine care to hospitalized patients. He approaches medicine as a craft, continually sharpening diagnostic reasoning and therapeutic decision-making in service of the best possible outcomes. He also values prevention and partners with patients to build sustainable habits that support long-term health and health span.
At New York University, Dr. Seddighzadeh received the Degree Representative Award, an honor conferred by the faculty recognizing the single graduating student with the highest overall academic achievement. He later earned a full-tuition scholarship from the founding dean to attend the University of Nevada, where he graduated with top honors in medicine. He went on to complete his internal medicine residency at Mayo Clinic where he was selected for the Resident Leadership Academy, a specialized program for residents identified across the Mayo Clinic enterprise as future leaders. There he also developed and launched the AI and Medicine Residency Track. He is currently a Clinical Informatics Fellow and internal medicine hospitalist at Stanford University. -
Mojtaba Sedigh Fazli
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Mojtaba Fazli is a leading scientist specializing in AI/ML, computer vision, and biomedical research. He is currently a Postdoctoral Research fellow Scientist at Stanford University and a Senior Research Fellow at the Harvard Ophthalmology Artificial Intelligence Lab, Harvard University, where he previously completed a postdoctoral fellowship.
Dr. Fazli's research bridges cutting-edge artificial intelligence with groundbreaking applications in multi-scale biomedical imaging, disease modeling, and drug discovery. His expertise encompasses advanced areas of AI/ML, including computer vision for 2D/3D medical image analysis, bioinformatics, and object tracking in both 2D and 3D environments. He has played a key role in developing state-of-the-art algorithms to enhance diagnostic precision and therapeutic outcomes within the biotechnology and healthcare sectors.
With a strong foundation in both academia and industry, Dr. Fazli previously served as a Senior Open Innovation Scholar at the Novartis Institute for Biomedical Research. There, he applied his expertise in strategic planning, programming, and simulation to tackle complex biomedical challenges.
Dr. Fazli holds a Ph.D. in Computer Science, with a minor in Mathematics, from the United States, as well as a Doctorate in Business Administration from France. His academic journey also includes master’s degrees in Economics and Management, as well as Artificial Intelligence and Robotics. His interdisciplinary approach blends AI-driven innovation with practical, impactful solutions in healthcare.
At Stanford, Dr. Fazli leads research initiatives focused on integrating multimodal data in rheumatology, advancing ultrasound imaging research in Rheumatoid Arthritis, and developing AI methodologies for clinical applications. His current work also involves leveraging Generative AI and Large Language Models (LLMs) to drive innovation in medical data analysis and clinical decision support. -
Laura Seeholzer
Assistant Professor of Neurobiology
BioMy laboratory studies how we detect, perceive, and respond to sensations from within our own bodies. We focus on understanding how the airways sense potentially harmful substances and trigger protective reflexes like coughing and sneezing. Using techniques ranging from molecular and biophysical studies of single cells to behavioral studies, we investigate how specialized epithelial cells lining the airways detect different types of stimuli and communicate this information to the nervous system. By studying epithelial cells from animal models and humans, we aim to understand how their dysfunction contributes to conditions like chronic cough and aspiration. We also examine how the brain processes these internal signals to create the conscious "urge" to cough or sneeze, and how we learn to suppress these reflexes in appropriate social contexts. This research advances our understanding of the fundamental mechanisms linking bodily sensations to conscious awareness, behavioral control, and disease.
I did my PhD at Rockefeller University with Dr. Vanessa Ruta and post-doctoral studies at UCSF with Dr. David Julius. -
Rebecca Seekamp, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsInterested in complementary/alternative medicine, international health, international adoption medicine and providing full spectrum health care.
-
George Segall
Professor of Radiology, Emeritus
Current Research and Scholarly InterestsScintigraphic evaluation of coronary blood flow and myocardial function using single photon emission computed tomography (SPECT) and positron emission tomography (PET). Tumor imaging and characterization of pulmonary nodules with PET/CT.
-
Niraj Sehgal
Clinical Professor, Medicine
Current Research and Scholarly InterestsQuality Improvement & Patient Safety, Teamwork & Communication, Leadership
Development, Organizational Culture & Change -
Carolyn Dacey Seib, MD, MAS
Associate Professor of Surgery (General Surgery)
BioDr. Carolyn Dacey Seib is a fellowship-trained endocrine surgeon and board-certified general surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. In 2025, she was among the first surgeons in the United States to earn a Focused Practice Designation in Complex Thyroid and Parathyroid Surgery from the American Board of Surgery, reflecting her expertise in these procedures and related patient management.
Dr. Seib provides comprehensive and personalized care for patients with thyroid, parathyroid, and adrenal disorders, including thyroid cancer, hyperthyroidism, primary hyperparathyroidism, primary aldosteronism, autonomous cortisol secretion, and pheochromocytomas. Her approach combines advanced surgical techniques with a focus on patient-centered outcomes, ensuring that each treatment plan is tailored to the individual.
In addition to her clinical practice, Dr. Seib is an NIH-funded researcher whose work focuses on optimizing surgical decision-making and outcomes for patients with endocrine disorders. She has received research support from the National Institute on Aging and the American Thyroid Association, and her studies have been published in leading peer-reviewed journals and featured in national media, including The New York Times.
Dr. Seib completed her undergraduate education at Princeton University (summa cum laude), earned her medical degree from the New York University School of Medicine, and completed her general surgery residency and endocrine surgery fellowship at the University of California, San Francisco (UCSF). -
Heather Selby, PhD
Basic Life Research Scientist, Stanford-Surgery Policy Improvement Research and Education Center
BioI am interested in developing medical imaging-based AI models to identify patients with locally advanced rectal cancer who achieve a clinical complete response to neoadjuvant chemoradiotherapy, with the goal of sparing them from surgery and its associated risks.
-
Zachary M. Sellers, MD, PhD
Adjunct Professor, Pediatrics - Gastroenterology
BioDr. Sellers is a pediatric physician-scientist and research and clinical development consultant. As a pediatric gastroenterologist and ion channel physiologist, Dr. Sellers' work in academia and pharma over the last 20 years has focused on improving the lives of individuals with complex and rare diseases through providing cutting-edge clinical care and advancing research and drug development. Dr. Sellers previously led a basic and translational research laboratory at Stanford, focused on epithelial ion transport and acid-base regulation using a variety of human and animal models. He is a firm believer in the exponential impact of team science and is adept working in multi-disciplinary and cross-functional teams. He seeks out strategic partnerships and opportunities that can leverage his expertise and leadership to advance innovative therapies for areas of high unmet need and to support the development of the next generation of physician-scientists. Dr. Sellers received his BS (Animal Physiology and Neuroscience) and BA (Japanese Studies) from the University of California. San Diego, his MD and PhD (Molecular and Integrative Physiology) from the University of Illinois at Urbana-Champaign, and was trained in Pediatrics and Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford, where he was previously a faculty member and attending physician. He held multiple leadership positions at Stanford, including Associate Chief of Research in Gastroenterology, Director of the Stanford Children's Pancreas Program, Lead Gastroenterologist for the CF Program, Director of the CFTR Phenotyping and Theratyping Program, and Physician-Scientist Advisor for the Pediatrics Residency Program.
-
Deborah Sellmeyer
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.
